Koshinski Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
+747
New +$277K 0.02% 629
2024
Q4
– Sell
-468
Closed -$243K – 638
2024
Q3
$243K Buy
468
+8
+2% +$4.27K 0.02% 538
2024
Q2
$244K Buy
+460
New +$243K 0.02% 510
2023
Q4
– Sell
-570
Closed -$248K – 540
2023
Q3
$248K Buy
570
+31
+6% +$14.1K 0.03% 468
2023
Q2
$239K Buy
539
+58
+12% +$26.8K 0.03% 506
2023
Q1
$221K Sell
481
-3
-0.6% -$1.43K 0.02% 513
2022
Q4
$248K Buy
+484
New +$246K 0.02% 508
2022
Q3
– Sell
-523
Closed -$252K – 587
2022
Q2
$252K Buy
+523
New +$259K 0.03% 501

Other funds holding ELV

Koshinski Asset Management's ELV Position: Q2 2026 in Review

Koshinski Asset Management opened a new position in Elevance Health (ELV) in Q2 2026: 747 shares worth $289K. The stake represents 0.02% of the portfolio and ranks #629 among its holdings. This is a return to the name: Koshinski Asset Management previously reported a position in ELV as recently as Q3 2024.

Koshinski Asset Management first reported a position in ELV in Q2 2022 and has held it in 8 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Koshinski Asset Management held 747 shares of Elevance Health worth $289K as of Q2 2026.
  • Elevance Health was a new Koshinski Asset Management position in Q2 2026.
  • Elevance Health made up 0.02% of Koshinski Asset Management's portfolio in Q2 2026, its #629 holding.
  • Koshinski Asset Management first reported a position in Elevance Health in Q2 2022 and has held it in 8 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.